The Lancet — The bottom line: We still don't know if aspirin therapy lowers the rate of first heart attacks and strokes in people at moderate risk for cardiovascular events, according to ARRIVE study research presented at the European Society of Cardiology Congress. |
|
No comments:
Post a Comment